Tuesday, July 21, witnessed the election of new ISEV President Clotilde Théry (photo) (https://en.wikipedia.org/wiki/Clotilde_Th%C3%A9ry), PhD, of the Institut Curie in Paris, and an electrifying scientific presentation on work involving exosomes, cardiology, and Duchenne muscular dystrophy (DMD), as two of many highlights of an action-packed Day 2 of the International Society for Extracellular Vesicles (ISEV) 2020 Virtual Annual Meeting (July 20-22) (https://www.eventscribe.com/2020/ISEV/). This year’s ISEV meeting has successfully gone virtual with 1,600 virtual attendees from 52 countries around the world, and is offering ~600 presentations of various types (Plenary Addresses, “Hot-Topic” Panel Sessions, Featured Abstracts, Oral Abstract Talks, Poster Chats, & Education Sessions), both live-streamed and on-demand, to its large international group of participants. Tuesday’s activities included the meeting’s third Plenary Address, presentation of the third of four ISEV Featured Abstracts, the ISEV General Assembly meeting at which new ISEV President Clotilde Thery was elected and three ISEV Special Achievement Awards were presented, the holding of highly informative Education Sessions 3 & 4, and presentations of key current technology by ISEV 2020’s Gold Sponsors. The meeting’s third Plenary Address, “Deconstructing Regenerative Medicine: From Cells to Exosomes and Defined Factors,” was delivered by Eduardo Marbán, MD, PhD, Founding Director, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles. Dr. Marbán is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene and stem cell therapies for heart disease. Those discoveries have formed the basis for multiple startup companies.Login Or Register To Read Full Story